Clinical Trials Directory

Trials / Unknown

UnknownNCT01237275

Development of A Technique to Predict Antidepressant Responsiveness in Depressive Patients

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
300 (estimated)
Sponsor
Samsung Medical Center · Academic / Other
Sex
All
Age
19 Years – 89 Years
Healthy volunteers
Accepted

Summary

First, the investigators examined the functional relevance of serotonin transporter polymorphisms by quantifying the activity of serotonin transporter in blood platelets of genotyped healthy volunteers and patients with major depression. Second, the investigators studied response to SSRIs in relation to 5-HTTLPR genotype and also to the functional expression of 5-HTT in platelets.

Detailed description

The purpose of this study is 1. to determine whether serotonin transporter genotypic or functional differences between depressive patients and normal controls were existed. 2. to determine the relationship between serotonin transporter polymorphisms and serotonin transporter functional expression. 3. to determine whether genomic or functional differences between drug responders and nonresponders predict the response of antidepressant

Conditions

Interventions

TypeNameDescription
DRUGSSRI treated groupcharacterize in arm of a study (SSRI treated group)

Timeline

Start date
1999-10-01
Primary completion
2003-12-01
Completion
2016-12-01
First posted
2010-11-09
Last updated
2015-12-31

Locations

1 site across 1 country: South Korea

Source: ClinicalTrials.gov record NCT01237275. Inclusion in this directory is not an endorsement.